IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 136 filers reported holding IMMUNOGEN INC in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,133,000 | +70.1% | 330,700 | -5.1% | 0.14% | +73.5% |
| Q3 2020 | $1,254,000 | -21.7% | 348,300 | 0.0% | 0.08% | -23.9% |
| Q2 2020 | $1,602,000 | +12.2% | 348,300 | -16.8% | 0.11% | -3.5% |
| Q1 2020 | $1,428,000 | +58.1% | 418,700 | +136.8% | 0.11% | +101.8% |
| Q4 2019 | $903,000 | -17.2% | 176,829 | +38.3% | 0.06% | -17.6% |
| Q1 2016 | $1,090,000 | -36.7% | 127,900 | +0.9% | 0.07% | -71.2% |
| Q4 2015 | $1,721,000 | +40.5% | 126,800 | -0.6% | 0.24% | +774.1% |
| Q3 2015 | $1,225,000 | +87.3% | 127,584 | +74.5% | 0.03% | +68.8% |
| Q1 2015 | $654,000 | +357.3% | 73,097 | +441.5% | 0.02% | +300.0% |
| Q3 2014 | $143,000 | -84.2% | 13,500 | -77.8% | 0.00% | -81.8% |
| Q1 2014 | $907,000 | +342.4% | 60,769 | +403.7% | 0.02% | +266.7% |
| Q3 2013 | $205,000 | – | 12,064 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |